Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
Bento L, Bastida JM, García-Cadenas I, García-Torres E, Rivera D, Bosch-Vilaseca A, De Miguel C, Martínez-Muñoz ME, Fernández-Avilés F, Roldán E, Chinea A, Yáñez L, Zudaire T, Vaz CP, Espigado I, López J, Valcárcel D, Duarte R, Cabrera R, Herrera C, González-Porras JR, Gutiérrez A, Solano C, Sampol A; Grupo Español de Trasplante Hematopoyético (GETH). Bento L, et al. Among authors: espigado i. Biol Blood Marrow Transplant. 2019 Sep;25(9):1825-1831. doi: 10.1016/j.bbmt.2019.05.023. Epub 2019 May 29. Biol Blood Marrow Transplant. 2019. PMID: 31152794 Free article. Clinical Trial.
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings.
Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Pérez-Oteyza J, Ferrá C, Zuazu J, Caballero D, Bargay J, Carvalhais A, Díez JL, Espigado I, Alegre A, Rovira M, Campilho F, Odriozola J, Sanz MA, Sierra J, García-Conde J, Montserrat E; Spanish Group for Allogeneic Peripheral Blood Transplantation (Grupo Español de Trasplante Hemopoyético) and Instituto Português de Oncologia-Porto. Urbano-Ispizua A, et al. Among authors: espigado i. Blood. 2002 Jul 15;100(2):724-7. doi: 10.1182/blood-2001-11-0057. Blood. 2002. PMID: 12091376 Free article.
Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
Moscardó F, Urbano-Ispizua A, Sanz GF, Brunet S, Caballero D, Vallejo C, Solano C, Pimentel P, Pérez de Oteyza J, Ferrá C, Díez-Martín JL, Zuazu J, Espigado I, Campilho F, Arbona C, Moraleda JM, Mateos MV, Sierra J, Talarn C, Sanz MA. Moscardó F, et al. Among authors: espigado i. Exp Hematol. 2003 Jun;31(6):545-50. doi: 10.1016/s0301-472x(03)00070-5. Exp Hematol. 2003. PMID: 12829031 Free article. Clinical Trial.
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
Pérez-García A, De la Cámara R, Román-Gómez J, Jiménez-Velasco A, Encuentra M, Nieto JB, de la Rubia J, Urbano-Ispizúa A, Brunet S, Iriondo A, González M, Serrano D, Espigado I, Solano C, Ribera JM, Pujal JM, Hoyos M, Gallardo D; GVHD/Immunotherapy Committee of the Spanish Group of Hematopoietic Stem Cell Transplantation. Pérez-García A, et al. Among authors: espigado i. Blood. 2007 Jul 1;110(1):461-7. doi: 10.1182/blood-2007-01-069781. Epub 2007 Mar 23. Blood. 2007. PMID: 17384200 Free article.
Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.
Gallardo D, de la Cámara R, Nieto JB, Espigado I, Iriondo A, Jiménez-Velasco A, Vallejo C, Martín C, Caballero D, Brunet S, Serrano D, Solano C, Ribera JM, de la Rubia J, Carreras E. Gallardo D, et al. Among authors: espigado i. Haematologica. 2009 Sep;94(9):1282-8. doi: 10.3324/haematol.2009.006924. Haematologica. 2009. PMID: 19734420 Free PMC article.
Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
Ferrá C, Sanz J, de la Cámara R, Sanz G, Bermúdez A, Valcárcel D, Rovira M, Serrano D, Caballero D, Espigado I, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM; GETH (Grupo Español de Trasplante Hematopoyético) and PETHEMA (Programa Español de Tratamiento en Hematología), Spanish Society of Hematology. Ferrá C, et al. Among authors: espigado i. Biol Blood Marrow Transplant. 2010 Jul;16(7):957-66. doi: 10.1016/j.bbmt.2010.02.003. Epub 2010 Feb 7. Biol Blood Marrow Transplant. 2010. PMID: 20144909 Free article.
Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays.
Gracia-Ahufinger I, Tormo N, Espigado I, Solano C, Urbano-Ispizua A, Clari MA, de la Cruz-Vicente F, Navarro D, Pérez-Romero P. Gracia-Ahufinger I, et al. Among authors: espigado i. J Clin Virol. 2010 Jun;48(2):142-6. doi: 10.1016/j.jcv.2010.03.015. Epub 2010 Apr 14. J Clin Virol. 2010. PMID: 20395168
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A; Spanish Network for Research on Infection in Transplantation (RESITRA/REIPI). Spain. Ruiz-Camps I, et al. Among authors: espigado i. Antivir Ther. 2011;16(7):951-7. doi: 10.3851/IMP1858. Antivir Ther. 2011. PMID: 22024510
114 results